/PRNewswire/ A Qualitative Research Study accomplished by Data Bridge Market research s titled as "Patau Syndrome Market" with 100+ market data Tables, Pie.
SYDNEY, Nov. 10, 2022 /PRNewswire/ A Qualitative Research Study accomplished by Data Bridge Market research's titled as "Patau Syndrome Market" with 100+ market data Tables, Pie Charts, Graphs
PerkinElmer Inc. (U.S.)
Eurofins LifeCodexx GmbH (Germany)
COVID-19 Pandemic to Have a Minimal Impact on NIPT Manufacturers
The COVID-19 pandemic has had an adverse effect on several industries across the world. Several reputed companies operating in the non-invasive prenatal testing industry are constantly keeping in touch with the U.S. FDA to get to know detailed information about supply chain disruptions. Also, research institutes are conducting many studies to determine the effect of the coronavirus on births and pregnancies. SeraCare’s report, for instance, declares that clinical testing laboratories and in-vitro diagnostics manufacturers are working closely to determine the interference of SARS-CoV-2 infection on childbirths.